Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

October 15, 2026

Study Completion Date

October 15, 2028

Conditions

Psoriatic Arthritis (PsA)

Interventions

DRUG

GLP-1 agonists

GLP-1, any assigned drug

OTHER

Nutrition Counseling

Nutrition Counseling in PsA

Trial Locations (1)

Medical College of Wisconsin/Froedtert Hosptial, Milwaukee

All Listed Sponsors

lead

Medical College of Wisconsin

OTHER